| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.2 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |